A recent US Supreme Court ruling on landowner property fees is getting drawn into the fight against a government drug price-setting program as drugmakers seek out additional defense against the negotiation scheme.
The US <-bsp-bb-link state="{"bbHref":"bbg://securities/13362Z%20US%20Equity","_id":"0000018f-0f88-d583-afbf-cfdcbadf0000","_type":"0000016b-944a-dc2b-ab6b-d57ba1cc0000"}">Federal Trade Commission voted Tuesday to adopt a near-total ban on non-compete provisions that prohibit workers from switching jobs within an industry, a rule the<-bsp-bb-link state="{"bbHref":"bbg://securities/0392381D%20US%20Equity","_id":"0000018f-0f88-d583-afbf-cfdcbadf0001","_type":"0000016b-944a-dc2b-ab6b-d57ba1cc0000"}">Chamber of Commerce vowed to immediately challenge in court.
Private equity firms and hedge funds would face greater scrutiny in buying California health-care facilities under a measure approved by a key legislative committee on Tuesday.
The vast majority of US nursing homes will have to beef up their staffing levels or face new penalties under terms of a new rule announced Monday by the Biden administration.
Abortion medical records will be better protected under a Biden administration rule issued Monday
The Biden administration’s push to improve nursing home care through better staffing—and the industry’s insistence that it needs more workers and funding to make it happen—could set the stage for intervention by Congress or the courts.
Early figures show that the CARE Court system, which has received about $200 million in state funding since 2022, has seen only a tiny fraction of the people it expected.
The US Supreme Court will consider just how far states can go in prohibiting abortion Wednesday as it weighs whether emergency room doctors nationwide can perform the procedure when a pregnant woman’s health is at serious risk.
Medicare’s recent decision to cover
Columnist David Lat explains the controversy behind universal injunctions and their impact on public policy and judicial power.
French drugmaker <-bsp-bb-link state="{"bbHref":"bbg://securities/SAN%20FP%20Equity/CACS","_id":"0000018f-0f4c-d583-afbf-cfdcfb9e0000","_type":"0000016b-944a-dc2b-ab6b-d57ba1cc0000"}">Sanofi has asked banks to pitch for roles on the separation of its consumer-health business, according to people familiar with the matter, one of the biggest deals likely to happen in Europe this year.
The European Union launched an investigation into China’s procurement of medical devices, the latest in a spate of actions that are raising tension ahead of President
Cartiva Inc., a medical device company focused on treating arthritis of the big toe, and its corporate parents were hit with a lawsuit alleging its synthetic cartilage implant was defectively designed and didn’t comply with post-approval requirements.
When do legal rights begin, at birth or before that? This video looks at the fetal personhood movement, and what it could mean for the future of abortion. We explore its history and the constitutional argument underpinning it.
Early figures show that the CARE Court system, which has received about $200 million in state funding since 2022, has seen only a tiny fraction of the people it expected.
Baker McKenzie is picking up a 17-lawyer corporate group from Munger, Tolles & Olson in Los Angeles, the latest move to expand its deals roster.
A pair of top
The US Supreme Court is poised to reckon with what constitutes an official presidential act in weighing former President Donald Trump’s claim that he’s immune from being criminally prosecuted for trying to overturn the 2020 election.
Norton Rose Fulbright’s Alesha Dominique and Ani Galoyan discuss AI in fashion and how recent lawsuits should push lawmakers to adapt legal frameworks around tech.
Columnist David Lat explains the controversy behind universal injunctions and their impact on public policy and judicial power.
Get the latest legal, regulatory, and enforcement news and analysis, as well as in-depth business and industry covering in the following areas: